FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing

FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing

Submitted by admin on December 23, 2019 - 11:46pm
Source: 
Pharmaforum
News Tags: 
FDA
AstraZeneca
Daiichi Sankyo
advanced breast cancer
Enhertu
Headline: 
FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing
snippet: 

The FDA has approved an advanced breast cancer drug from AstraZeneca and Daiichi Sankyo in super-quick time.

Do Not Allow Advertisers to Use My Personal information